These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 342483)

  • 41. Action of 3-deazaguanine in Escherichia coli.
    Saunders PP; Chao LY; Robins RK; Loo TL
    Mol Pharmacol; 1979 May; 15(3):691-7. PubMed ID: 386079
    [No Abstract]   [Full Text] [Related]  

  • 42. Treatment of urinary infections: clinical perspectives.
    Fontana G; Laudi M; Carlone NA; Savoia D
    Chemioterapia; 1987 Feb; 6(1):45-9. PubMed ID: 3549009
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Mechanisms of action of chemotherapeutic drugs--microcalorimetric studies].
    Allerberger F; Dierich MP
    Wien Klin Wochenschr; 1989 Mar; 101(7):221-3. PubMed ID: 2652889
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Transfer to Escherichia coli K 12 of resistance factors and bacteriocinogenic factors from Shigella sonnei].
    Hamon Y; Szturm-Rubinsten S; Floch T; Peron Y
    Ann Inst Pasteur (Paris); 1971 Dec; 121(6):743-50. PubMed ID: 4948139
    [No Abstract]   [Full Text] [Related]  

  • 45. Drug dependence and phenotype masking in streptomycin dependent and paromomycin dependent mutants of Escherichia coli.
    Quesnel LB; York P; Skinner VM
    Microbios; 1971 Sep; 4(14):97-107. PubMed ID: 4949967
    [No Abstract]   [Full Text] [Related]  

  • 46. Frequency and expression of mutational resistance to the 4-quinolone antibacterials.
    Smith JT
    Scand J Infect Dis Suppl; 1986; 49():115-23. PubMed ID: 3547618
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanism of action of showdomycin. V. Reduced ability of showdomycin-resistant mutants of Escherichia coli K-12 to take up showdomycin and nucleosides.
    Komatsu Y
    J Antibiot (Tokyo); 1971 Dec; 24(12):876-83. PubMed ID: 4946509
    [No Abstract]   [Full Text] [Related]  

  • 48. [Change in behavior of mice and rats under the effect of dimethyl-2,2 hydroxymethyl-4 dioxolanne-1,3 (glycerol acetonide)].
    Cheav SL; Ziade FF; Foussard-Blanpin O
    Ann Pharm Fr; 1986; 44(6):487-94. PubMed ID: 3619328
    [No Abstract]   [Full Text] [Related]  

  • 49. Basically substituted dioxolanes and dioxanes.
    Gisvold O; Maulding HV
    J Pharm Sci; 1968 May; 57(5):784-7. PubMed ID: 4872497
    [No Abstract]   [Full Text] [Related]  

  • 50. [Studies on pathogenic Escherichia coli. (III) Multiple drug resistance of capsular polysaccharide-synthesizing Escherichia coli of clinical origins (author's transl)].
    Tseng CC; Chen MY; Lee LW
    Taiwan Yi Xue Hui Za Zhi; 1979 Jan; 78(1):7-16. PubMed ID: 376779
    [No Abstract]   [Full Text] [Related]  

  • 51. [A comparative study of the action of antibiotics on enteropathogenic Escherichia coli serotypes].
    Anan'ev PK; Petrov VM; Tiurina LA
    Veterinariia; 1966 Apr; 43(4):17-9. PubMed ID: 4861973
    [No Abstract]   [Full Text] [Related]  

  • 52. Evidence for separation of anesthetic activity from prototypic phencyclidine action in drug discrimination by molecular modification of dioxadrol, a phencyclidine-like dissociative anesthetic.
    Harrison EA; Rafferty MF; Rice KC; Creveling CR; Winger GD; Woods JH; Jacobson AE
    NIDA Res Monogr; 1984; 55():90-6. PubMed ID: 6100507
    [No Abstract]   [Full Text] [Related]  

  • 53. [Relationship between bacterial resistance to antibiotics and to the bacteriophage ZAR2].
    Wilckens R; García-Quintana H
    Zentralbl Veterinarmed B; 1981; 28(5):371-7. PubMed ID: 7034409
    [No Abstract]   [Full Text] [Related]  

  • 54. [Clinical study of cinoxacin in acute simple cystitis].
    Inaba T; Watanabe H; Ohe H
    Hinyokika Kiyo; 1986 Feb; 32(2):293-6. PubMed ID: 3524157
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Microcalorimetric study of the effect of Benzoinum and Styrax on the growth of Escherichia coli.
    Wang J; Cheng D; Zeng N; Xia H; Fu Y; Yan D; Zhao Y; Xiao X
    Nat Prod Res; 2011 Feb; 25(4):457-63. PubMed ID: 21328140
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A microcalorimetric method for studying the toxic effect of different diphenol species on the growth of Escherichia coli.
    Chen H; Yao J; Wang Y; Tian L; Wang F; Djak A; Choi MM; Bramanti E
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2007 Apr; 42(5):613-20. PubMed ID: 17454368
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changes in drug resistance of shigellae, salmonellae and Escherichia coli.
    Anzai H; Nakamura T
    Kitasato Arch Exp Med; 1968 Jun; 41(1):11-23. PubMed ID: 4896191
    [No Abstract]   [Full Text] [Related]  

  • 58. Transferable antibiotic resistance in Escherichia coli.
    Datta N
    Proc R Soc Med; 1971 May; 64(5):533-4. PubMed ID: 4930727
    [No Abstract]   [Full Text] [Related]  

  • 59. [Mechanism of action of nourseothricin and bacterial resistance and cross-resistance to this antibiotic].
    Haupt I; Thrum H
    Arch Exp Veterinarmed; 1986 Sep; 40(5):676-81. PubMed ID: 3028299
    [No Abstract]   [Full Text] [Related]  

  • 60. In vitro activity of prulifloxacin against Escherichia coli isolated from urinary tract infections and the biological cost of prulifloxacin resistance.
    Gualco L; Schito AM; Schito GC; Marchese A
    Int J Antimicrob Agents; 2007 Jun; 29(6):679-87. PubMed ID: 17363225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.